Tamoxifen-melatonin hybrid ligands as novel potent agents against breast cancer / Mohamed Akmal Mohamed Aly Marzouk ; Supervised Darius P. Zlotos
Material type:
- الروابط الهجينية التاموكسيفين- الميلاتونين كمواد جديدة قوية ضد سرطان الثدي [Added title page title]
Item type | Current library | Home library | Call number | Status | Barcode | |
---|---|---|---|---|---|---|
![]() |
قاعة الثقاقات الاجنبية - الدور الثالث | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.34.M.Sc.2018.Mo.T (Browse shelf(Opens below)) | Not for loan | 01010110078251000 |
Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceutical Chemistry
Breast cancer is one of the most common type of cancer among woman worldwide.Tamoxifen is commonly used to prevent and treat estrogen receptor positive (ER+) breast cancer. However, its chronic use can increase the risk of uterine cancer and induce tamoxifen resistance
There are no comments on this title.